These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

505 related items for PubMed ID: 21657888

  • 1. Higher metabolic risk with National Institutes of Health versus Rotterdam diagnostic criteria for polycystic ovarian syndrome in Turkish women.
    Anaforoglu I, Algun E, Incecayir O, Ersoy K.
    Metab Syndr Relat Disord; 2011 Oct; 9(5):375-80. PubMed ID: 21657888
    [Abstract] [Full Text] [Related]

  • 2. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC, Galluzzo A, Finocchiaro S, Criscimanna A, Giordano C.
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
    [Abstract] [Full Text] [Related]

  • 3. Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome.
    Toscani M, Migliavacca R, Sisson de Castro JA, Spritzer PM.
    Metabolism; 2007 Jul; 56(7):992-7. PubMed ID: 17570263
    [Abstract] [Full Text] [Related]

  • 4. Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria.
    Goverde AJ, van Koert AJ, Eijkemans MJ, Knauff EA, Westerveld HE, Fauser BC, Broekmans FJ.
    Hum Reprod; 2009 Mar; 24(3):710-7. PubMed ID: 19095675
    [Abstract] [Full Text] [Related]

  • 5. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.
    Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H.
    Hum Reprod; 2012 Oct; 27(10):3067-73. PubMed ID: 22777527
    [Abstract] [Full Text] [Related]

  • 6. Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria.
    Kauffman RP, Baker TE, Baker VM, DiMarino P, Castracane VD.
    Am J Obstet Gynecol; 2008 Jun; 198(6):670.e1-7; discussion 670.e7-10. PubMed ID: 18355776
    [Abstract] [Full Text] [Related]

  • 7. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF, Li X, Zhu MW.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [Abstract] [Full Text] [Related]

  • 8. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H, Tanir HM, Yildiz Z.
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [Abstract] [Full Text] [Related]

  • 9. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM, Wass JA, McCarthy MI, Franks S.
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
    [Abstract] [Full Text] [Related]

  • 10. The insulin-resistant phenotype of polycystic ovary syndrome.
    Svendsen PF, Madsbad S, Nilas L.
    Fertil Steril; 2010 Aug; 94(3):1052-8. PubMed ID: 19580964
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome.
    Lankarani M, Valizadeh N, Heshmat R, Peimani M, Sohrabvand F.
    Gynecol Endocrinol; 2009 Aug; 25(8):504-7. PubMed ID: 19499403
    [Abstract] [Full Text] [Related]

  • 12. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors.
    Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC.
    BJOG; 2006 Oct; 113(10):1210-7. PubMed ID: 16972863
    [Abstract] [Full Text] [Related]

  • 13. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.
    Moran L, Teede H.
    Hum Reprod Update; 2009 Oct; 15(4):477-88. PubMed ID: 19279045
    [Abstract] [Full Text] [Related]

  • 14. The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome.
    Hahn S, Fingerhut A, Khomtsiv U, Khomtsiv L, Tan S, Quadbeck B, Herrmann BL, Knebel B, Müller-Wieland D, Mann K, Janssen OE.
    Clin Endocrinol (Oxf); 2005 May; 62(5):573-9. PubMed ID: 15853827
    [Abstract] [Full Text] [Related]

  • 15. Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment.
    Amato MC, Guarnotta V, Forti D, Donatelli M, Dolcimascolo S, Giordano C.
    Hum Reprod; 2013 Jul; 28(7):1919-28. PubMed ID: 23592224
    [Abstract] [Full Text] [Related]

  • 16. [Interrelationship of abnormal family history in the first degree relatives and clinical phenotype of patients with polycystic ovary syndrome].
    Wang Y, Mao WW, Chen YJ, Li MZ, Qiao J, Wang LN.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):756-60. PubMed ID: 18307903
    [Abstract] [Full Text] [Related]

  • 17. Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study.
    Dalamaga M, Papadavid E, Basios G, Vaggopoulos V, Rigopoulos D, Kassanos D, Trakakis E.
    J Am Acad Dermatol; 2013 Dec; 69(6):922-30. PubMed ID: 24120563
    [Abstract] [Full Text] [Related]

  • 18. [Metformin, an efficacious drug in the treatment of polycystic ovary syndrome].
    Hahn S, Quadbeck B, Elsenbruch S, Gärtner R, Finke R, Mann K, Janssen OE.
    Dtsch Med Wochenschr; 2004 May 07; 129(19):1059-64. PubMed ID: 15136950
    [Abstract] [Full Text] [Related]

  • 19. Is there a role for insulin resistance in nonobese patients with idiopathic hirsutism?
    Abdel Fattah NS, Darwish YW.
    Br J Dermatol; 2009 May 07; 160(5):1011-5. PubMed ID: 19298279
    [Abstract] [Full Text] [Related]

  • 20. Body mass index and ovarian function are associated with endocrine and metabolic abnormalities in women with hyperandrogenic syndrome.
    Cupisti S, Kajaia N, Dittrich R, Duezenli H, W Beckmann M, Mueller A.
    Eur J Endocrinol; 2008 May 07; 158(5):711-9. PubMed ID: 18426831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.